Gynecomastia, the growth of breast tissue in males, is driven by a shift in the balance between estrogen and testosterone. Dealing with it depends on what’s causing that shift, how long it’s been present, and how much tissue has developed. Options range from waiting it out, to medication that can shrink early-stage growth, to surgery for persistent or severe cases.
Why Male Breast Tissue Grows
In men, estrogen and testosterone exist in a careful balance that normally prevents breast tissue from developing. Estrogen stimulates breast growth, while testosterone has the opposite effect. Anything that tips this ratio, either by raising estrogen or lowering testosterone, can trigger the breast tissue to enlarge. Only about 15% of estrogen in men comes directly from the testes. The rest is produced throughout the body when an enzyme called aromatase converts testosterone and related hormones into estrogen. So even normal testosterone levels can lead to gynecomastia if aromatase activity is elevated or if testosterone’s effects are being blocked.
Common triggers include puberty (when hormone levels fluctuate dramatically), aging (as testosterone gradually declines), obesity (fat tissue is rich in aromatase, producing more estrogen), alcohol use, and certain medications. Rarer causes include thyroid disorders, kidney disease, liver disease, and testosterone-producing or estrogen-producing tumors.
Medications That Can Cause It
Several widely prescribed drugs are linked to gynecomastia. Spironolactone, a blood pressure and heart failure medication, has the strongest evidence. It appears to cause breast enlargement through a hormonal mechanism, shifting the estrogen-to-testosterone ratio directly. The effect is more common at higher doses and tends to cause bilateral (both sides) growth that isn’t always painful.
Other medications associated with gynecomastia include finasteride (used for hair loss and prostate enlargement), certain antidepressants like fluoxetine, paroxetine, and venlafaxine, and cytotoxic drugs used in cancer treatment. For most of these drugs, breast enlargement is rare and may represent an unusual individual reaction rather than a predictable side effect. If you notice breast tissue changes after starting a new medication, your prescriber can evaluate whether switching to an alternative is appropriate.
True Gynecomastia vs. Chest Fat
Not all male breast enlargement involves actual glandular tissue. Pseudogynecomastia is enlargement caused purely by fat deposits, with no firm glandular component. The distinction matters because it changes your treatment path. A simple physical exam can usually tell the difference: when a doctor presses from both sides of the breast toward the nipple, true gynecomastia produces a firm, rubbery disc of tissue centered directly behind the nipple. With pseudogynecomastia, there’s no resistance until the fingers reach the nipple itself, just soft fatty tissue throughout.
If the cause is purely excess fat, weight loss is often the most effective approach, and surgical options would lean toward liposuction rather than tissue excision.
When It Resolves on Its Own
If you’re a teenager or the parent of one, the most important thing to know is that pubertal gynecomastia resolves without treatment in 75 to 90% of cases, typically within one to three years. The hormonal swings of puberty temporarily shift the estrogen-to-testosterone ratio, and once testosterone levels stabilize, the breast tissue usually regresses.
For this reason, doctors generally recommend a period of observation of at least 12 months before considering any intervention in adolescents. Treatment is typically reserved for cases that persist beyond that window, cause significant pain or tenderness, or create serious psychological distress. In adults, gynecomastia that’s been present for more than a year is less likely to resolve spontaneously because the tissue may become more fibrous over time.
How Severity Is Graded
Doctors classify gynecomastia into four grades based on the amount of tissue and whether excess skin is present:
- Grade I: Small enlargement with no excess skin
- Grade IIa: Moderate enlargement with no excess skin
- Grade IIb: Moderate enlargement with minor excess skin
- Grade III: Marked enlargement with significant excess skin, resembling female breast shape
Grade I and IIa cases are the most responsive to non-surgical treatment. Grade IIb and III cases are more likely to require surgery, particularly when skin needs to be removed or the nipple repositioned.
Medication Treatment for Early Cases
For gynecomastia that’s relatively recent (generally under 12 months) and still in the active growth phase, medications that block estrogen’s effect on breast tissue can be effective. Tamoxifen, taken at 20 mg daily for 6 to 12 weeks, resolved breast enlargement in about 83% of patients in one clinical study. It worked significantly better on firm glandular lumps (100% response) compared to fatty-type tissue (62.5% response). The medication also resolved breast tenderness in 84% of cases where pain was present.
These medications work best when the tissue is still soft and growing. Once gynecomastia has been present for a long time and the tissue becomes dense and fibrous, medication is much less likely to produce meaningful results. This is why early evaluation matters if the condition isn’t resolving on its own.
What Happens During Surgery
Surgery becomes the primary option when gynecomastia is longstanding, large, or unresponsive to other approaches. The technique depends on what type of tissue is involved. When the enlargement is mostly fatty, liposuction alone may be sufficient. When firm glandular tissue is present, direct excision through a small incision is needed. Excision is also necessary when the areola needs to be made smaller or the nipple repositioned. Many procedures combine both liposuction and excision.
Recovery After Surgery
Most people who undergo a combined liposuction and excision procedure return to work within seven to ten days, depending on how physical the job is. You’ll wear a compression garment around your chest after surgery, with the duration varying based on your surgeon’s assessment of your healing. Strenuous activity, especially anything involving the chest and arms, should be avoided for two to three weeks. Low-impact exercise can typically resume at weeks two to three, and gentle upper body resistance training can begin between three and six weeks post-surgery.
Lifestyle Steps That Help
While no lifestyle change alone will eliminate established glandular tissue, several practical steps can reduce the hormonal imbalance that drives gynecomastia or prevent it from worsening. Losing excess body fat is one of the most impactful, since fat tissue actively converts testosterone to estrogen. Reducing alcohol intake helps because alcohol can suppress testosterone production and increase estrogen. Strength training, particularly compound movements, supports healthy testosterone levels.
If you’re using anabolic steroids or testosterone supplements, these are a well-known cause. The body compensates for the influx of external testosterone by increasing aromatase activity, converting more of it to estrogen. Stopping the external source is the first step, though some cases triggered by steroid use become permanent if left untreated for too long.
Getting a Proper Evaluation
A thorough evaluation typically includes a physical exam to distinguish glandular tissue from fat and to check for any concerning features like hard, fixed lumps or changes in the skin. Blood work measures testosterone, estrogen, luteinizing hormone, and sometimes other markers depending on the clinical picture. If estrogen levels are elevated and there’s concern about a testicular cause, an ultrasound of the testes may be ordered. A mammogram is reserved for cases where physical findings raise suspicion for breast cancer, which is rare in men but not impossible.
The evaluation helps pinpoint a treatable cause. Gynecomastia linked to a medication, a thyroid problem, or low testosterone can often be addressed by treating the underlying issue rather than the breast tissue itself.